Your browser doesn't support javascript.
loading
Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment.
Winckelmann, Anni; Fahnøe, Ulrik; Bajpai, Priyanka Shukla; Dalegaard, Magnus Illum; Lundh, Andreas; Ryom, Lene; Bukh, Jens; Weis, Nina.
Afiliação
  • Winckelmann A; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: anniw@dadl
  • Fahnøe U; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Bajpai PS; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dalegaard MI; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Lundh A; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Cochrane Denmark & Centre for Evidence-Based Medicine Odense, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Ryom L; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; CHIP, Centre of Excellence for Health, Immunity and Infections, section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bukh J; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Weis N; Department of Infectious Diseases, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
J Clin Virol ; 150-151: 105159, 2022 06.
Article em En | MEDLINE | ID: mdl-35487093

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Organofosfonatos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Virol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Organofosfonatos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Virol Ano de publicação: 2022 Tipo de documento: Article